Satellite Sites
Peninsula Medical Centre offers a well-established, scalable environment for clinical trial delivery in primary care.
With experienced personnel, integrated infrastructure, and strong access to diverse patient populations, the site is well positioned to support efficient recruitment, high-quality participant care, and protocol-compliant study delivery. Located near Te Atatū / Henderson motorway interchange.
Clinical Trials Capability
- Proven experience integrating clinical trials into primary care workflows
- Access to a broad, diverse patient population suitable for multi-indication recruitment
- Established systems supporting protocol delivery, participant management, and follow-up
Experienced Trial Personnel
Delivery is supported by an experienced multidisciplinary team with prior involvement in site-based research and clinical trial operations.
Katarina O’Connor, Clinical Trial Manager
Experienced in leading site-based research operations, including oversight of an active trial unit. Brings 20+ years’ experience across hospital and corporate healthcare settings.
Dr Gene Dillman, MD, FRNZCGP, Sub-Investigator & General Practitioner
Vocationally registered GP and Fellow of the Royal New Zealand College of General Practitioners. US-trained and practising in New Zealand since 2014.
Tyronne Tranquilino, Nurse Team Leader
Experienced nurse leader with prior clinical trial involvement, supporting study delivery within primary care.
Patient Population & Recruitment Potential
The centre serves approximately 11,400 enrolled patients across two sites, providing strong recruitment potential across multiple therapeutic areas.
Ethnic diversity:
- European: 42%
- Asian: 23%
- Māori: 17%
- Pacific: 12%
Age profile:
- <14 years: 22%
- 25–44 years: 53%
- 45–64 years: 23%
- 65+: 13%
Chronic disease cohorts:
- Diabetes: 659
- Asthma: 1,225
- Osteoarthritis: 591
- Atrial fibrillation: 197
- COPD: 45
This profile supports studies in chronic disease, respiratory, cardiovascular, and musculoskeletal conditions, as well as trials prioritising diverse populations.
